We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
-16.94%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$11.9B
AUM Growth
-$3.87B
Cap. Flow
-$755M
Cap. Flow %
-6.32%
Top 10 Hldgs %
21.67%
Holding
1,534
New
61
Increased
492
Reduced
593
Closed
262

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$59.4M
2
BABA icon
Alibaba
BABA
+$52.4M
3
UNH icon
UnitedHealth
UNH
+$43.7M
4
ABT icon
Abbott
ABT
+$42.2M
5
AGN
Allergan plc
AGN
+$40.4M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$59.1M
2
FISV
Fiserv Inc
FISV
+$45.8M
3
CMCSA icon
Comcast
CMCSA
+$44.7M
4
BAX icon
Baxter International
BAX
+$40M
5
TMO icon
Thermo Fisher Scientific
TMO
+$38.7M

Sector Composition

Rank Sector Weight
1 Technology 23.72%
2 Healthcare 19.62%
3 Financials 12.72%
4 Consumer Discretionary 10.57%
5 Communication Services 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NE
1226
DELISTED
Noble Corporation
NE
$22K ﹤0.01%
83,612
-1,047,849
-93% -$780K
BELFB
1227
Bel Fuse Inc Class B
BELFB
$3.6B
$21K ﹤0.01%
2,183
– –
EPD icon
1228
Enterprise Products Partners
EPD
$82.5B
$20K ﹤0.01%
1,400
– –
SPN
1229
DELISTED
Superior Energy Services, Inc.
SPN
$20K ﹤0.01%
+13,300
New +$52.4K
GGB icon
1230
Gerdau
GGB
$9.74B
$19K ﹤0.01%
12,374
– –
SBSI icon
1231
Southside Bancshares
SBSI
$960M
$19K ﹤0.01%
639
-14,608
-96% -$494K
IOVA icon
1232
Iovance Biotherapeutics
IOVA
$2.09B
$18K ﹤0.01%
600
– –
THFF icon
1233
First Financial Corp
THFF
$961M
$17K ﹤0.01%
511
-2,551
-83% -$103K
TILE icon
1234
Interface
TILE
$1.96B
$17K ﹤0.01%
2,258
-50,902
-96% -$710K
ADAP
1235
DELISTED
Adaptimmune Therapeutics
ADAP
$16K ﹤0.01%
5,900
– –
FTEK icon
1236
Fuel Tech
FTEK
$44.9M
$16K ﹤0.01%
40,394
+25,599
+173% +$19.7K
KRYS icon
1237
Krystal Biotech
KRYS
$10.8B
$16K ﹤0.01%
375
– –
SGMO
1238
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$15K ﹤0.01%
2,300
– –
PRLB icon
1239
Protolabs
PRLB
$1.79B
$13K ﹤0.01%
165
– –
MRNS
1240
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$13K ﹤0.01%
1,600
– –
NTLA icon
1241
Intellia Therapeutics
NTLA
$1.55B
$12K ﹤0.01%
1,020
– –
RGNX icon
1242
Regenxbio
RGNX
$648M
$12K ﹤0.01%
360
– –
BLFS icon
1243
BioLife Solutions
BLFS
$1.55B
$10K ﹤0.01%
1,100
– –
FL
1244
DELISTED
Foot Locker
FL
$10K ﹤0.01%
440
-418
-49% -$14.2K
QEP
1245
DELISTED
QEP RESOURCES, INC.
QEP
$10K ﹤0.01%
28,510
-335,279
-92% -$807K
MAT icon
1246
Mattel
MAT
$4.42B
$7K ﹤0.01%
845
-4,238
-83% -$52K
ADVM
1247
DELISTED
Adverum Biotechnologies
ADVM
$1K ﹤0.01%
10
– –
AA icon
1248
Alcoa
AA
$11.9B
– –
-2,252
Closed -$48K
AAON icon
1249
Aaon
AAON
$7.17B
– –
-3,633
Closed -$120K
ABG icon
1250
Asbury Automotive
ABG
$4.34B
– –
-10,369
Closed -$1.16M
48 49
50
51 52

Similar funds

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking Tokyo, Japan $40.6B AUM 25.18% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

KBC Group's Q1 2020 Portfolio in Review

As of Q1 2020, KBC Group held 1,534 positions worth $11.9B, down 24% from $15.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

KBC Group withdrew a net $755M in Q1 2020, closing 262 positions and reducing 593 holdings. Its most notable exit was TransDigm Group, an estimated $18M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, KBC Group opened a new position in Ingersoll Rand worth $12.3M.

  • KBC Group's largest Q1 2020 buy was Ingersoll Rand: 495,850 shares worth $12.3M.
  • KBC Group added most to Medtronic in Q1 2020, an estimated $59.4M increase.
  • KBC Group's biggest Q1 2020 reduction was Alphabet (Google) Class A, cutting an estimated $59.1M.
  • KBC Group fully exited TransDigm Group in Q1 2020, selling an estimated $18M.
  • KBC Group's ten largest holdings make up 22% of its $11.9B portfolio in Q1 2020.
  • KBC Group opened 61 new positions and closed 262 in Q1 2020.
  • KBC Group's portfolio value fell 24% quarter-over-quarter to $11.9B.

Based on KBC Group's 13F filing for Q1 2020, filed 4 May 2020.